Natixis Advisors
AVNS

Natixis Advisors’s Avanos Medical AVNS Stock Holding History

Natixis Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,903
Closed -$242K – 1603
2025
Q3 		$242K Sell
20,903
-31,984
-60% -$375K ﹤0.01% 1608
2025
Q2 		$647K Buy
52,887
+33,163
+168% +$417K ﹤0.01% 1421
2025
Q1 		$283K Sell
19,724
-6,220
-24% -$97.1K ﹤0.01% 1558
2024
Q4 		$413K Buy
25,944
+4,492
+21% +$88.9K ﹤0.01% 1509
2024
Q3 		$515K Buy
21,452
+2,574
+14% +$58.8K ﹤0.01% 1448
2024
Q2 		$376K Buy
18,878
+3,077
+19% +$59.9K ﹤0.01% 1484
2024
Q1 		$315K Buy
15,801
+1,659
+12% +$32.1K ﹤0.01% 1470
2023
Q4 		$317K Buy
+14,142
New +$292K ﹤0.01% 1458
2023
Q3 		– Sell
-18,217
Closed -$466K – 1487
2023
Q2 		$466K Buy
18,217
+2,877
+19% +$75.8K ﹤0.01% 1353
2023
Q1 		$456K Buy
15,340
+1,721
+13% +$50K ﹤0.01% 1327
2022
Q4 		$369K Buy
+13,619
New +$333K ﹤0.01% 1361
2022
Q2 		– Sell
-11,287
Closed -$378K – 1457
2022
Q1 		$378K Buy
+11,287
New +$364K ﹤0.01% 1333

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's AVNS Position: Q4 2025 in Review

Natixis Advisors sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 20,903 shares — an estimated $242K sold.

Natixis Advisors first reported a position in AVNS in Q1 2022 and held it in 12 quarters. The position peaked at $647K in Q2 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Natixis Advisors reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Natixis Advisors sold 20,903 Avanos Medical shares in Q4 2025, an estimated $242K.
  • Natixis Advisors first reported a position in Avanos Medical in Q1 2022 and held it in 12 quarters.
  • Natixis Advisors's Avanos Medical position peaked at $647K in Q2 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Natixis Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.